2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …
G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …
M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …
detailed information, the user should always access to the full text version of the guidelines …
Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration
Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first
diagnosed at the time of stroke. Detecting asymptomatic AF would provide an opportunity to …
diagnosed at the time of stroke. Detecting asymptomatic AF would provide an opportunity to …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz… - Ep …, 2015 - academic.oup.com
The current manuscript is an update of the original Practical Guide, published in June 2013
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve …
Task Force Members, GYH Lip… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion–an update
M Glikson, R Wolff, G Hindricks, J Mandrola… - EP …, 2020 - academic.oup.com
This article has been co-published with permission in EP Europace and EuroIntervention. All
rights reserved. VC 2019 the European Heart Rhythm Association and the European …
rights reserved. VC 2019 the European Heart Rhythm Association and the European …
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - EP …, 2016 - academic.oup.com
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …
Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials
L Fauchier, B Pierre, A de Labriolle, C Grimard… - Journal of the American …, 2008 - jacc.org
Objectives: To improve the evaluation of the possible antiarrhythmic effect of statins, we
performed a meta-analysis of randomized trials with statins on the end point of incidence or …
performed a meta-analysis of randomized trials with statins on the end point of incidence or …
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …
N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …